GlaxoSmithKline Intellectual Property Development Limited
发明人:
申请号：
EP18830414.1
公开号：
EP3724187A1
申请日:
2018.12.12
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, L and A are as defined in the description and claims, or pharmaceutically acceptable salts thereof having mTOR kinase inhibitor activity. The invention also relates to pharmaceutical compositions including a compound of formula (I) or a pharmaceutically acceptable salt thereof, and to the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in therapy, including in the treatment of a disease or condition for which an mTOR kinase inhibitor activity is indicated, and in particular the treatment of idiopathic pulmonary fibrosis.
